Tuberculin-specific T cells are reduced in active pulmonary tuberculosis compared to LTBI or status post BCG vaccination

Journal of Infectious Diseases

Volumn 203, Issue 3, 2011, Pages 378-382

  Streitz, Mathias ^a   Fuhrmann, Stephan ^b,d   Powell, Fiona ^d   Quassem, Ali ^c   Nomura, Laurel ^e   Maecker, Holden ^f   Martus, Peter ^a   Volk, Hans Dieter ^a   Kern, Florian ^a,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HELIOS KLINIKUM BERLIN BUCH   (Germany)

^c Lungenklinik Lostau gGmbH   (Germany)

^d BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^e BD BIOSCIENCES   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD40 LIGAND; ETHAMBUTOL; GAMMA INTERFERON; INTERLEUKIN 2; ISONIAZID; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PYRAZINAMIDE; RIFAMPICIN; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGRANULATION; FEMALE; FLOW CYTOMETRY; HUMAN; INTERFERON PRODUCTION; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MALE; PRIORITY JOURNAL; TUBERCULIN TEST; UPREGULATION;

ADULT; BCG VACCINE; CD40 LIGAND; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTES; TUBERCULIN; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79751494486     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq065     Document Type: Article

References (15)

1. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008; 177:1164-70. (Pubitemid 351717577)
2. Kaufmann SH. How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 2001; 1:20-30.
3. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with Infliximab, a Tumor Necrosis Factor {alpha}-neutralizing agent. N Engl J Med 2001; 345:1098-1104.
4. Darrah PA, Patel DT, De Luca PM, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007; 13:843-850. (Pubitemid 47038186)
5. Pantaleo G, Koup RA. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat Med 2004; 10:806-810. (Pubitemid 39070851)
6. Lindenstrom T, Agger EM, Korsholm KS, et al. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol 2009; 182:8047-55.
7. Diagnostic standards and classification of tuberculosis in adults and children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161:1376-95.
8. Betts MR, Brenchley JM, Price DA, et al. Sensitive and viable identification of antigen-specific CD81 T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281:65-78. (Pubitemid 37324571)
9. Maecker HT, Rinfret A, D'Souza P, et al. Standardization of cytokine flow cytometry assays. BMC Immunol 2005; 6:13.
10. Streitz M, Tesfa L, Yildirim V, et al. Loss of receptor on tuberculinreactive T-cells marks active pulmonary tuberculosis. PLoS ONE 2007; 2:e735.
11. Caccamo N, Guggino G, Joosten SA, et al. Multifunctional CD4+T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol. 2010; 40(8):2211-20.
12. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 2009; 39:723-9.
13. Vekemans J, Lienhardt C, Sillah JS, et al. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in the Gambia. Infect Immun 2001; 69:6554-7. (Pubitemid 32885227)
14. Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 2008; 8:247-58. (Pubitemid 351432801)
15. Soares AP, Scriba TJ, Joseph S, et al. Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol 2008; 180:3569-77.